Scopolamine Transdermal System Patch, Extended Release
Product Images NDC 45802-580

9 FDA label images from Padagis Israel Pharmaceuticals Ltd · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Scopolamine Transdermal System (NDC 45802-580). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Israel Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Carton Rev05 19

Carton Rev05 19
Packaging label for Scopolamine Transdermal System 1 mg/3 days, a patch extended release medication. The label displays the product name prominently with strength and dosage interval, indicates it is for motion sickness and post-operative nausea and vomiting prevention. The label also includes 24 transdermal systems per package and manufacturer details for Padagis Israel Pharmaceuticals Ltd and distributor Perrigo. Additional instructions and cautionary text appear on the side panel.*
FDA Label Image

Cross Section

Cross Section
An illustration showing the layered structure of the Scopolamine Transdermal System patch. It identifies the layers from top to bottom as Backing Membrane, Drug Layer, Rate Controlling Membrane, Contact Layer, and Release Liner.*
FDA Label Image

Figure 1

Figure 1
Illustration showing a Scopolamine Transdermal System patch with labeled components including a clear, disposable release liner, a metallic adhesive surface, and a tan backing membrane imprinted with "SCOP 1 mg/3 days." The diagram highlights the patch's design for extended release over three days.*
FDA Label Image

Figure 2

Figure 2
An instructional diagram showing a sealed transdermal patch package with a dashed line for cutting open. It includes a scissor icon indicating where to cut along the dashed line to open the package, labeled as Figure 2.*
FDA Label Image

Figure 3

Figure 3
Illustration showing hands peeling apart the packaging of a transdermal patch, revealing the patch inside. This image likely demonstrates how to open the Scopolamine Transdermal System patch packaging.*
FDA Label Image

Figure 4

Figure 4
An instructional illustration showing a person holding the Scopolamine Transdermal System patch, highlighting its components: an imprinted tan-colored transdermal system, a metallic adhesive surface, and a disposable plastic backing. The figure demonstrates how to handle the patch prior to application.*
FDA Label Image

Figure 5

Figure 5
An illustration showing the application site for the Scopolamine Transdermal System patch. The diagram depicts a side profile of a person's head with the tan-colored patch placed behind the ear, indicating proper placement on the skin for transdermal delivery.*
FDA Label Image

Serialization Template

Serialization Template
Label panel for Scopolamine Transdermal System patch showing placeholders for serial number (S/N), lot number, and expiration date (Exp). The label indicates where this product identification information should be inserted but contains no actual serial, lot, or expiration data.*
FDA Label Image

Structure

Structure
Chemical structure of scopolamine, the active ingredient in Scopolamine Transdermal System.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.